Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-24 @ 7:45 PM
NCT ID:
NCT00216203
Eligibility Criteria:
Inclusion Criteria:
* Histologic or cytologic diagnosis of NSCLC
* Recurrent or metastatic disease that is not amenable to curative therapyMeasurable disease according to RECIST
* At least one prior platinum containing regimen for either locally advanced or metastatic disease
* Prior chemotherapy must be completed at least 21 days prior to being registered for protocol therapy and the subject must have recovered from the acute toxicity effects of the regimen
* Ability and willingness to interrupt aspirin or other nonsteroidal anti-inflammatory agents for a 5-day period
* Prior radiation therapy allowed to \< 25% of the bone marrow
* Negative pregnancy test
Exclusion Criteria:
* No active infection that in the opinion of the investigator would compromise the subject's ability to tolerate therapy.
* No serious concomitant systemic disorders that would compromise the safety of the subject or compromise the subject's ability to complete the study, at the discretion of the investigator.
* No prior malignancy is allowed except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the subject has been disease-free for at least 2 years.
* No major thoracic or abdominal surgery within 30 days prior to being registered for protocol therapy.
* No current breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00216203
Study Brief:
Protocol Section:
NCT00216203